Schedule 13G ownership disclosure

ATARA BIOTHERAPEUTICS INC

Security class unavailable · CUSIP: 046513107

Event date: 2023-11-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,067,043
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-23-000715
Form type
SC 13G
Filer
Atara Biotherapeutics, Inc.
CIK
CIK 1604464
Filed
Nov 21, 2023
Reporting period
Nov 16, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G | SEC Filings Hub